Absci (ABSI) EBT Margin (2020 - 2026)

Absci (ABSI) reported EBT Margin of 13758.6% for Q1 2026, down 1152366.0% on a YoY basis from N/an in Q1 2025, and down 200.87% sequentially from 4572.92% in Q4 2025.

Absci (ABSI) EBT Margin (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of EBT Margin data on file, last reported at 13758.6% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 1152366.0% year-over-year to 13758.6%; the trailing twelve-month figure through Mar 2026 stood at 6445.81% (down 421480.0% YoY), and the FY2025 full-year result was 4111.21%, down 183870.0% from the prior year.
  • EBT Margin fell to 13758.6% in Q1 2026, from 4572.92% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1237.33% in Q2 2023 to a low of 13758.6% in Q1 2026.
  • A 5-year average of 4755.85% and a median of 4355.19% in 2024 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin jumped 945100 bps in 2022 and sank 1152366 bps in 2026, its largest moves.
  • Tracing ABSI's EBT Margin over 5 years: stood at 5891.15% in 2022, then declined by 18 bps to 6951.78% in 2023, then soared by 37 bps to 4355.19% in 2024, then dropped by 5 bps to 4572.92% in 2025, then slumped by 201 bps to 13758.6% in 2026.
  • Business Quant data shows ABSI's EBT Margin at 13758.6% in Q1 2026, 4572.92% in Q4 2025, and 7566.67% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Absci 1.23 Bn 1.11 Bn - -13,758.60%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13,758.60%
Dec 31, 2025 -4,572.92%
Sep 30, 2025 -7,566.67%
Jun 30, 2025 -5,132.88%
Mar 31, 2025 -2,234.94%
Dec 31, 2024 -4,355.19%
Sep 30, 2024 -1,608.52%
Jun 30, 2024 -1,948.82%
Mar 31, 2024 -2,445.77%
Dec 31, 2023 -6,951.78%
Sep 30, 2023 -2,951.61%
Jun 30, 2023 -1,237.33%
Mar 31, 2023 -1,839.87%
Dec 31, 2022 -5,891.15%
Sep 30, 2022 -7,553.70%
Jun 30, 2022 -2,889.22%
Mar 31, 2022 -7,910.41%
Dec 31, 2021 1,222.34%
Sep 30, 2021 -17,004.70%
Jun 30, 2021 -6,430.63%